ARQT - Arcutis Biotherapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARQT is currently covered by 11 analysts with an average price target of $29.96. This is a potential upside of $15.39 (105.63%) from yesterday's end of day stock price of $14.57.

Arcutis Biotherapeutics 's activity chart (see below) currently has 46 price targets and 79 ratings on display. The stock rating distribution of ARQT is 87.23% BUY and 12.77% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 24.44% with an average time for these price targets to be met of 64.6 days.

Highest price target for ARQT is $21, Lowest price target is $15, average price target is $18.63.

Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 03-Apr-2025. First documented stock forecast 25-Feb-2020.

Currently out of the existing stock ratings of ARQT, 41 are a BUY (87.23%), 6 are a HOLD (12.77%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$20

$5.27 (35.78%)

$20

6 days ago
(03-Apr-2025)

3/18 (16.67%)

$3.84 (23.76%)

275

Buy

$19

$4.27 (28.99%)

$19

6 days ago
(03-Apr-2025)

0/4 (0%)

$2.84 (17.57%)

Buy

6 days ago
(03-Apr-2025)

1/1 (100%)

$9.67 (36.73%)

27

Hold

$15

$0.27 (1.83%)

$11

1 months 13 days ago
(27-Feb-2025)

3/5 (60%)

$2.2 (17.19%)

41

Buy

$21

$6.27 (42.57%)

$20

1 months 14 days ago
(26-Feb-2025)

3/17 (17.65%)

$8.8 (72.13%)

273

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ARQT (Arcutis Biotherapeutics ) average time for price targets to be met?

On average it took 64.6 days on average for the stock forecasts to be realized with a an average price target met ratio 24.44

Which analyst has the current highest performing score on ARQT (Arcutis Biotherapeutics ) with a proven track record?

GRAIG SUVANNAVEJH

Which analyst has the most public recommendations on ARQT (Arcutis Biotherapeutics )?

Graig Suvannavejh works at MIZUHO and has 3 price targets and 5 ratings on ARQT

Which analyst is the currently most bullish on ARQT (Arcutis Biotherapeutics )?

Graig Suvannavejh with highest potential upside - $36.28

Which analyst is the currently most reserved on ARQT (Arcutis Biotherapeutics )?

Chris Shibutani with lowest potential downside - -$8.73

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?